Market Overview

Benzinga's Top Downgrades

Share:
Related ATU
6 Stocks Which Rallied Four Days, Then Sold Off Yesterday
Barclays Ratings And Price Target Changes For July 11
Notable earnings before Wednesday's open (Seeking Alpha)
Related XYL
Benzinga's Top Upgrades
Xylem Acquisition Of Sensus A 'Bold, Strategic Move'

Analysts at Citigroup downgraded Actuant (NYSE: ATU) from “buy” to “neutral.” Actuant's shares closed at $25.81 yesterday. Actuant's trailing-twelve-month ROE is 14.43%.

Analysts at Goldman downgraded Xylem (NYSE: XYL) from “neutral” to “sell.” Xylem's shares closed at $24.29 yesterday. Xylem's PEG ratio is 2.33.

Analysts at Bernstein downgraded Weatherford International Ltd (NYSE: WFT) from “outperform” to “market perform.” Weatherford's shares closed at $12.24 yesterday. Weatherford's trailing-twelve-month profit margin is 2.53%.

JMP Securities downgraded Anthera Pharmaceuticals (NASDAQ: ANTH) from “outperform” to “market perform.” Anthera Pharmaceuticals' shares closed at $2.75 yesterday. Anthera Pharmaceuticals' trailing-twelve-month ROA is -92.62%.

Latest Ratings for ATU

DateFirmActionFromTo
May 2016TopekaInitiates Coverage onHold
Apr 2016BMO CapitalInitiates Coverage onMarket Perform
Mar 2016Gabelli & Co.DowngradesBuyHold

View More Analyst Ratings for ATU
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (ATU + ANTH)

View Comments and Join the Discussion!